Documentos relacionados

1. Emerging drugs for the treatment of primary biliary cholangitis.
2. Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis.
3. Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.
4. [Progresses and hot spots of primary biliary cholangitis in the past decade].
5. UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis.
6. Pharmacotherapy for primary biliary cholangitis: an assessment of medication candidacy and rates of treatment.
7. [Interpretation of key points of the technical guidelines for clinical trials of drugs for the treatment of primary biliary cholangitis].
8. A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis.
9. Response to Ursodeoxycholic Acid May Be Assessed Earlier to Allow Second-Line Therapy in Patients with Unresponsive Primary Biliary Cholangitis.
10. Clinical outcomes and sick leave in relation to UDCA treatment in Swedish patients with primary biliary cholangitis.